openPR Logo
Press release

Acne Drugs Market

10-12-2020 01:50 PM CET | Health & Medicine

Press release from: IMARC Group

According to IMARC Group’s latest report, titled “Acne Drugs Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025,”. Looking forward, IMARC Group expects the global acne drugs market to continue its moderate growth during the next five years.

Acne drugs are medications used to treat a dermatological infection caused by the inflammation in the hair follicles on the skin. It is generally due to hormonal imbalance, oily skin, accumulation of dead skin cells, bacteria, stress, inadequate water intake, and excessive consumption of sugars, salts, or carbohydrates. Few acne drugs are topical medications, such as retinoids, salicylic and azelaic acid-based ointments, and dapsone-based gels, coupled with antibiotics, anti-androgen agents, and isotretinoin. These drugs reduce oil production in the body, accelerate skin cell turnover, reduce acne breakouts, scarring, damage the skin, and prevent inflammation.

Request for a free sample copy of this report: https://www.imarcgroup.com/acne-drugs-market/requestsample

Market Trends

The growing incidences of skin-related diseases, such as acne vulgaris, are driving the acne drug market. Moreover, increasing awareness towards the benefits of using premium skin care products and the emergence of effective therapeutics and treatments with lower side effects are augmenting the market growth. Additionally, the growing traction for products containing natural ingredients has compelled the manufacturers to develop products infused with natural herbs and organic ingredients to treat acne. Furthermore, elevating consumer disposable income levels and the growing popularity of customized acne drugs as per the user’s skin type, are expected to propel the acne drugs market.

Acne Drugs Market 2020-2025 Analysis and Segmentation:

Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these key players include:

• Allergan Plc
• Bausch Health Companies Inc.
• Bayer Aktiengesellschaft
• Cipher Pharmaceuticals Inc.
• Galderma Holding SA
• Johnson & Johnson
• Pfizer Inc.
• Reckitt Benckiser Group Plc
• Skinvisible Pharmaceuticals Inc.
• Sun Pharmaceutical Industries Limited
• Teva Pharmaceutical Industries Ltd

The report has segmented the market on the basis of acne type, drug class, drug type, route of administration and region.

Breakup by Acne Type:
• Comedonal
• Inflammatory
• Cystic
• Postsurgical/Wound

Breakup by Drug Class:
• Retinoids
• Antibiotics
• Hormonal Agents
• Combination Drugs
• Others

Breakup by Drug Type:
• OTC Drugs
• Prescription Drugs

Breakup by Route of Administration:
• Topical
• Oral
• Injectable

Breakup by Region:
• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa

Contact US:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Email: sales@imarcgroup.com
USA: +1-631-791-1145
Follow us on twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Acne Drugs Market here

News-ID: 2155744 • Views:

More Releases from IMARC Group

Germany Residential Real Estate Market 2024: Size, Share, Growth, Outlook, & Forecast Report by 2032
Germany Residential Real Estate Market 2024: Size, Share, Growth, Outlook, & For …
The latest report by IMARC Group, titled "Germany Residential Real Estate Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2032," offers a comprehensive analysis of the market. The report also includes competitor and regional analysis, along with a breakdown of segments within the industry. The Germany residential real estate market is projected to exhibit a growth rate (CAGR) of 4.40% during 2024-2032. Germany Residential Real Estate Market Trends: The Germany residential real
Germany LED Lighting Market Share, Size, Top Brands, Demand Analysis, & Forecast Report 2024-2032
Germany LED Lighting Market Share, Size, Top Brands, Demand Analysis, & Forecast …
The latest report by IMARC Group, titled "Germany LED Lighting Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2032," offers a comprehensive analysis of the market. The report also includes competitor and regional analysis, along with a breakdown of segments within the industry. The Germany LED lighting market is projected to exhibit a growth rate (CAGR) of 10.40% during 2024-2032. Germany LED Lighting Market Trends: The market in Germany is primarily driven
Germany Cold Chain Logistics Market 2024: Industry Analysis, Growth Rate, & Research Report 2032
Germany Cold Chain Logistics Market 2024: Industry Analysis, Growth Rate, & Rese …
The latest report by IMARC Group, titled "Germany Cold Chain Logistics Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2032," offers a comprehensive analysis of the market. The report also includes competitor and regional analysis, along with a breakdown of segments within the industry. The Germany cold chain logistics market is projected to exhibit a growth rate (CAGR) of 11.50% during 2024-2032. Germany Cold Chain Logistics Market Trends: The market in Germany
GCC Electric Car Market Overview, Industry Growth Rate, Research Report 2024-2032
GCC Electric Car Market Overview, Industry Growth Rate, Research Report 2024-203 …
IMARC Group, a leading market research company, has recently releases report titled "GCC Electric Car Market Report by Type (Battery Electric Vehicle, Plug-In Hybrid Electric Vehicle, Fuel Cell Electric Vehicle), Vehicle Class (Mid-Priced, Luxury), Vehicle Drive Type (Front Wheel Drive, Rear Wheel Drive, All-Wheel Drive), and Country 2024-2032". The study provides a detailed analysis of the industry, including the GCC electric car market share, size, trends, and growth forecasts. The

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug